✦ LIBER ✦

Effect of an alpha-glucosidase inhibitor (BAY m 1099) on post-prandial blood glucose and insulin in type II diabetics

✍ Scribed by P. H. Joubert; W. J. Bam; N. Manyane

Publisher: Springer
Year: 1986
Tongue: English
Weight: 260 KB
Volume: 30
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00614315

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduction of postprandial blood glucose

Reduction of postprandial blood glucose by theα-glucosidase inhibitor Miglitol (BAY m 1099) in Type II diabetes

✍ G. Heinz; M. Komjati; A. Korn; W. Waldhäusl 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 502 KB

Effects of theα-glucosidase inhibitor 1

Effects of theα-glucosidase inhibitor 1 desoxynojirimycin (BAY M 1099) on postprandial blood glucose, serum insulin and C-peptide levels in type II diabetic patients

✍ Ch. Schnack; G. Röggla; A. Luger; G. Schernthaner 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 294 KB

The effect of a new specificα-amylase in

The effect of a new specificα-amylase inhibitor on post-prandial glucose and insulin excursions in normal subjects and Type 2 (non-insulin-dependent) diabetic patients

✍ H. G. Eichler; A. Korn; S. Gasic; W. Pirson; J. Businger 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 324 KB

Trestatin (Ro 9-0154), a new specific alpha-amylase inhibitor of microbial origin, was tested in six normal subjects and seven Type 2 (non-insulin-dependent) diabetic patients. In normal subjects the maximal increases in blood glucose following a 115-g starch meal were 2.19 +/- 0.57 mmol/l (mean +/-